ArticleOncotarget2018

The estrogen receptor variants β2 and β5 induce stem cell characteristics and chemotherapy resistance in prostate cancer through activation of hypoxic signaling.

Michelle Faria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.